References

  1. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006; 20:W13-23. PubMed | Google Scholar

  2. Holguins A, Hertog K, Soriano V. Performance of drug resistance assays in testing HIV non-B subtypes. Journal of clinical microbiology and infectious diseases. 2003; 9 (4): 323-326. PubMed | Google Scholar

  3. Mwau M, Adungo F, Kadima S et al. Evaluation of PIMA Point of Care Technology for CD4 T Cell Enumeration in Kenya. PLoS ONE. 2013; 8(6): e67612. PubMed | Google Scholar

  4. Desai M, Iyer G, Dikshit RK. Antiretroviral drugs: Critical issues and recent advances. Indian J Pharmacol. 2012; 44 (3): 288-298. PubMed | Google Scholar

  5. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. Crystal structures at 3.5, A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 1992; (5065) 256: 1783-1790. PubMed | Google Scholar

  6. Sundquist WI, Kräusslich HG. Assembly, budding and maturation. Cold Spring Harb Perspect Med. 2011; 10.110. PubMed | Google Scholar

  7. Hsu A, Granneman GR, Cao G et al. Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir. Clin Pharmacol Ther. 1998; 63(4): 453-464. PubMed | Google Scholar

  8. Yao X, Wainberg MA, Parniak MA. Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris. Virology. 1991; 187(1): 56 - 62. PubMed | Google Scholar

  9. Japour AJ, Mayers DI, Johnson VA, Kuritzkes DR et al. Standardized Peripheral Blood Mononuclear Cell Culture Assay for Determination of Drug Susceptibilities of Clinical Human ImmunodeficiencyVirusTyp1 Isolates.Antimicrobial agents and Chemotherapy.1993; 37(5): 1095-1101. PubMed | Google Scholar

  10. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65 (1-2): 55-63. PubMed | Google Scholar

  11. Emerging Infectious Diseases? www.cdc.gov/eid ? Vol. 10, No. 4, April 2004. Accessed on May 27 2015. Google Scholar

  12. Birk M, Sonnerborg T. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment- naive patients. AIDS. 1998; 12 (18): 2369-75. PubMed | Google Scholar

  13. Bannister WP, Ruiz L, Loveday C et al. HIV-1 subtypes and response to combination antiretroviral therapy in Europe. Antivir Therapy. 2006; 11(6): 707-15. PubMed | Google Scholar

  14. Hermans P, Schmit JC, Kabeya K, O'Doherty E, De Wit S, Sommereijns B, Clumeck N.Virological Response to Salvage Therapy at 6 Months in Patients with B or Non-B Subtypes. 9th Conference on Retroviruses and Opportunistic Infections. 2002; 24-28-4. PubMed | Google Scholar